Myderm Medical New Soothing Hemorrhoidal Spray
NDC Package 72667-287-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Myderm Medical New Soothing Hemorrhoidal (witch hazel penylephrine lidocaine) sprays is • Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. This formulation utilizes a spray delivery system. Marketed by Inspec Solutions, this product is identified by NDC 72667-287 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
72667-287-05
Package Description
127 g in 1 CAN
Product Code
72667-287
11-Digit Billing Format
72667028705
RxNorm Crosswalk
  • RxCUI: 2099775 - lidocaine hydrochloride 5 % / phenylephrine hydrochloride 0.25 % / witch hazel 50 % Topical Spray
  • RxCUI: 2099775 - lidocaine hydrochloride 50 MG/ML / phenylephrine hydrochloride 2.5 MG/ML / witch hazel 500 MG/ML Topical Spray

Clinical Specifications

Proprietary Name
Myderm Medical New Soothing Hemorrhoidal
Non-Proprietary Name
Witch Hazel Penylephrine Lidocaine
Substance Name
Lidocaine Hydrochloride; Phenylephrine Hydrochloride; Witch Hazel
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
• Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. • Children under 2 years of age: Consult physician.

Regulatory & Marketing

Labeler Name
Inspec Solutions
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-01-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72667-287-05 identifies a specific commercial package of 127 g in 1 can of Myderm Medical New Soothing Hemorrhoidal, a human over the counter drug labeled by Inspec Solutions. This spray is formulated for topical use and contains lidocaine hydrochloride; phenylephrine hydrochloride; witch hazel as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Inspec Solutions on December 01, 2025. The current certification is valid through December 31, 2027.

How is this Inspec Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72667028705. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72667-287-05
11-Digit CMS (5-4-2)
72667-0287-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.